Ex parte BERG - Page 11




          Appeal No. 93-3114                                                          
          Application 07/825,465                                                      
          Fusobacterium necrophorum cells are gram-negative bacterial                 
          cells (Spec., p. 1, lines 8-14; Maas, Chapter I, Introduction,              
          p. 2, first paragraph).                                                     
               Adams teaches that Fusobacterium necrophorum is                        
          responsible for foot rot and liver abscesses and other lesions              
          in ruminant animals (Adams, col. 1, lines 34-51).  Adams                    
          utilized mice as models for determining the activity of                     
          compounds against Fusobacterium necrophorum infection in                    
          ruminant animals (Adams, col. 8, Example 2).                                
               We conclude that persons having ordinary skill in the                  
          art in view of the combined prior art teachings reasonably                  
          would have been led to expect success in treating cattle with               
          B-propiolactone-inactivated Fusobacterium necrophorum bacterin              
          to prevent or control foot rot or liver necrosis.  We agree                 
          with the examiner’s view that a reasonable expectation of                   
          success is required and not absolute predictability to sustain              
          a rejection for unpatentability under 35 U.S.C. § 103.                      
          Compare In re O’Farrell, 853 F.2d 894, 903, 7 USPQ2d 1673,                  
          1681 (Fed. Cir. 1988).                                                      
               While appellant’s view that persons having ordinary skill              
          in the art would not have been led by the combined prior art                


                                       - 11 -                                         





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007